Why March Determines 2026 Shared Savings
Most ACO leaders think the Shared Savings story is written in December.
It is not.
By the time Q4 arrives, the financial trajectory for 2026 is largely locked in. Attribution patterns are stable. Quality workflows are embedded. Documentation habits are set. Care coordination gaps are either corrected or cemented.
March is where that trajectory quietly forms.
If you lead an Accountable Care Organization under the Medicare Shared Savings Program, this month is not about reporting. It is about structural decisions that will shape your 2026 Shared Savings distribution, your quality performance score, and your audit defensibility.
Let me show you why.
1. Shared Savings Is Built on Early-Year Operational Design
Under the Medicare Shared Savings Program (MSSP), your Shared Savings payment depends on two major pillars:
Total cost of care performance against the benchmark
Quality performance score
Most ACOs place a heavy emphasis on year-end financial reconciliation. Fewer focus on what I call “March alignment.”
March alignment includes:
Care management staffing allocation
Attribution review
High-risk patient targeting methodology
Documentation governance standards
APP reporting workflow design
Promoting Interoperability compliance tracking
Security Risk Assessment documentation review
If these elements are misaligned in March, your quality score and cost curve drift in opposite directions.
That is how ACOs miss savings while thinking they are compliant.
2. Attribution Stabilizes Early. Act Like It.
CMS beneficiary attribution does not wait for your strategic planning retreat.
By March, patterns of patient engagement, visit distribution, and primary care anchoring are already forming. If you have not reviewed attribution drivers this month, you are reacting instead of leading.
Action Steps for March:
Pull your preliminary attribution file and compare against last year’s March baseline.
Identify beneficiary leakage to non-participating specialists.
Review primary care visit patterns for high-risk patients.
Confirm that care coordination outreach aligns with attributed population segments.
If attribution drifts by even 2 to 3 percent, your total cost performance model shifts materially.
That is not theoretical. A 1 percent change in benchmark variance across a 15,000-beneficiary ACO can represent hundreds of thousands in Shared Savings opportunity.
March is when you can still intervene.
3. Quality Score Sensitivity Is Underestimated
Under APP reporting within the Quality Payment Program, small quality score fluctuations have amplified effects in MSSP.
Many ACOs assume quality scoring is stable year to year. That assumption is dangerous.
Three things are happening in 2026:
Quality benchmarks are increasingly competitive.
Data completeness thresholds are scrutinized.
Documentation audits are more documentation-focused than score-focused.
If your data completeness rate is marginal in March, your denominator risk compounds all year.
What to Review This Month:
Measure-by-measure completeness rates
Variability across TINs
Outlier practices dragging composite performance
Workflow bottlenecks in quality documentation capture
If one TIN is underperforming in documentation capture, do not wait until mid-year.
Correct it now.
4. Promoting Interoperability Is Not a Technical Category. It Is a Risk Category.
Many ACO leaders assume Promoting Interoperability is an IT issue.
It is not.
PI performance influences your MIPS APM score. Your MIPS APM score influences financial exposure for participating clinicians. That exposure affects provider satisfaction and retention.
More importantly, PI failure can trigger audit scrutiny. In March, you should:
Confirm completion and documentation of your Security Risk Assessment.
Verify mitigation steps are documented, not just planned.
Review numerator logic for e-prescribing and patient access measures.
Ensure AI-assisted documentation workflows have human review oversight.
Do not assume your EHR vendor is handling compliance. Accountability rests with the ACO.
A PI documentation gap discovered in Q4 cannot be corrected retroactively.
March is your last comfortable window for correction.
5. Reweighting Assumptions Are Not a Strategy
Hardship exemptions and automatic reweighting policies are narrower in 2026.
If any participating clinician assumes reweighting will protect them, you are building financial strategy on uncertainty.
This month, you should:
Identify clinicians considering hardship exemption.
Validate eligibility against current CMS guidance.
Model financial impact if exemption is denied.
Develop contingency plans for PI or Quality performance optimization.
An ACO that relies on reweighting rather than performance optimization exposes itself to avoidable revenue loss.
March is when you either build resilience or build excuses.
6. Early Cost Curve Analysis Predicts Year-End Performance
Many ACO finance teams wait until mid-year to evaluate total cost trends. That is late. By March, you already have early claims run-out data and utilization signals.
Look specifically at:
Avoidable emergency department utilization
Post-acute spend patterns
Skilled nursing facility length-of-stay trends
High-cost imaging utilization rates
If your cost trend is 1 to 2 percent above benchmark trajectory in March, that deviation rarely self-corrects.
Intervention at this stage includes:
Intensifying transitional care management outreach
Revising preferred post-acute provider alignment
Engaging high-utilizer case conferences
Recalibrating risk stratification thresholds
Financial modeling done in March gives you runway.
Financial modeling done in August gives you regret.
7. Audit Preparedness Is a Financial Strategy
CMS data validation cycles and documentation requests are increasingly detailed.
If your organization cannot produce:
Timestamped quality documentation
SRA mitigation logs
Governance committee minutes
AI workflow oversight documentation
Attribution methodology rationale
You are exposed.
Audit recoupment risk affects not only current performance year, but reputation and future participation decisions. March is the appropriate time to conduct a mock audit review. Use this structure:
Select three APP measures.
Pull 10 charts per measure.
Validate numerator logic against documentation.
Confirm traceability from EHR extraction to submission file.
If you cannot defend your documentation trail now, you will not defend it later.
8. Two-Sided Risk Decisions Should Not Be Emotional
Many ACOs default to upside-only tracks out of perceived safety. In reality, two-sided risk can offer higher Shared Savings rates and more predictable strategic alignment. March is when you should:
Model downside exposure under Track 1 Enhanced or similar structures.
Compare potential Shared Savings percentage differences.
Evaluate capital reserve capacity.
Assess care management infrastructure maturity.
Avoid emotional decision-making. Use modeling.
If two-sided risk offers stronger long-term positioning and your operational foundation supports it, March is when the conversation should occur.
9. AI in Compliance Workflows Requires Governance
AI tools are increasingly used for:
Documentation summarization
Quality abstraction support
Risk stratification
Care gap identification
CMS has not prohibited AI-assisted workflows. However, responsibility remains human.
In March:
Document AI usage policies.
Define review accountability.
Maintain audit trails for AI-assisted outputs.
Conduct periodic accuracy validation sampling.
If AI improves efficiency but weakens the defensibility of documentation, it is not an advantage.
It is a liability.
10. What High-Performing ACOs Do in March
From our advisory work, high-performing ACOs treat March as a recalibration month.
They:
Run early cost and quality sensitivity models.
Conduct attribution stability reviews.
Validate SRA documentation completion.
Align care management incentives with high-risk segments.
Audit APP reporting workflows.
Reassess risk track decisions using updated financial modeling.
They do not wait for mid-year panic. They build financial confidence early. How do we know? We taught them.
Just the FAQs
Does March performance truly influence year-end Shared Savings?
Yes. Operational patterns, documentation quality, and attribution stability established in Q1 create performance inertia.
Is it too early to run cost modeling?
No. Early claims and utilization patterns are predictive. Modeling in March provides strategic runway.
Should we conduct an internal audit now?
Yes. A documentation audit in March identifies remediable gaps.
Is two-sided risk too aggressive?
Not necessarily. It depends on capital reserves, infrastructure maturity, and performance modeling.
Here’s the thing:
Shared Savings is not won in December; It is engineered in March. If you treat this month as administrative, you will likely spend Q4 reacting. If you treat it as a strategic priority, you build leverage. Now is the time to:
Run attribution sensitivity models.
Validate APP documentation.
Confirm PI compliance readiness.
Conduct internal audit sampling.
Reassess risk track strategy.
Model financial impact under multiple scenarios.
If you would like support reviewing your 2026 Shared Savings positioning, schedule a strategy session with our team.
Because in MSSP, the most expensive mistake is assuming there is still time later.
There usually is not.
